VITEX AGNUS-CASTUS

OTHER NAME(S):

Agni Casti, Agnocasto, Agnolyt, Agnus-Castus, Chaste Berry, Agneau du Moine, Agneau-chaste, Agni Casti, Agnocasto, Agnolyt, Agnus-Castus, Arbre au Poivre, Chaste Berry, Chaste Tree, Chaste Tree Berry, Chasteberry, Chastetree, Chinese Vitex, Gattilier, Hemp Tree, Herbe au Poivre, Mang Jing Zi, Monk's Pepper, Petit Poivre, Pimiento del Monje, Poivre de Moine, Poivre Sauvage, Vitex, Vitex Agnus Castus, Vitex rotundifolia, Vitex trifolia, Viticis Fructus.<br/><br/>

Overview

Overview Information

Vitex agnus-castus tree is a shrub that is native to the Mediterranean and Central Asia. The shrub has long, finger-shaped leaves, blue-violet flowers, and dark purple berries. The fruit and seed are used to make medicine.

Vitex agnus-castus is commonly taken by mouth for conditions related to the menstrual cycle such as premenstrual syndrome and a more severe form called premenstrual dysphoric disorder. It is also used for "lumpy" breasts and and many other conditions.

How does it work?

Vitex agnus-castus seems to affect many hormones that are involved in women's reproductive cycle.

Uses

Uses & Effectiveness?

Possibly Effective for

  • Premenstrual dysphoric disorder. Some research shows that vitex agnus-castus might work about as well as the prescription drug fluoxetine (Prozac) for relieving symptoms of this condition. Vitex agnus-castus seems to be better for physical symptoms like breast tenderness, swelling, and cramps. Fluoxetine seems to be better for depressed mood, feeling nervous and feeling out of control.
  • Premenstrual syndrome. Some research shows that taking vitex agnus-castus decreases some symptoms, especially breast pain or tenderness, depressed mood or moodiness, anger, and headache. But it does not seem to help for bloating.

Possibly Ineffective for

  • Bone fractures. Taking vitex agnus-castus extract does not seem to improve the healing of broken bones.

Insufficient Evidence for

  • Bleeding caused by an intrauterine device. Early research shows that taking vitex agnus-castus three times daily might reduce bleeding caused by an intrauterine device.
  • Infertility. The effects of vitex agnus-castus on fertility is not clear. Some early research shows that it does not improve the chance of becoming pregnant in women with infrequent menstrual bleeding, but it might help those who do not produce enough progesterone.
  • Repelling insects. Early research shows that vitex agnus-castus seed extract repels ticks and fleas for 6 hours, mosquitoes for 3 to 8 hours, and biting flies for 3 hours, when applied to the skin.
  • Breast pain. Early research shows that vitex agnus-castus) might relieve breast pain.
  • Acne.
  • Dementia.
  • Enlarged prostate.
  • Eye pain.
  • Increasing lactation.
  • Insomnia.
  • Menopausal symptoms.
  • Nervousness.
  • Prevention of miscarriage.
  • Swelling.
  • Other conditions.
More evidence is needed to rate the effectiveness of vitex agnus-castus for these uses.

Side Effects

Side Effects & Safety

Vitex agnus-castus fruit extract is LIKELY SAFE for most people when taken by mouth appropriately. Uncommon side effects include upset stomach, nausea, itching, rash, headaches, acne, trouble sleeping, and weight gain. Some women notice a change in menstrual flow when they start taking vitex agnus-castus. Vitex-agnus-castus seed extract is POSSIBLY SAFE when applied to the skin appropriately.

Special Precautions & Warnings:

Pregnancy and breast-feeding: Using vitex agnus-castus during pregnancy or breast-feeding is POSSIBLY UNSAFE. The concern is that vitex agnus-castus can interfere with hormones. Don't use vitex agnus-castus if you are pregnant or breast-feeding.

Hormone-sensitive conditions such as endometriosis; uterine fibroids; or cancer of the breast, uterus, or ovaries: Vitex agnus-castus can affect hormones and might affect estrogen levels. Don't use vitex agnus-castus if you have a hormone-sensitive condition.

In vitro fertilization: Vitex agnus-castus can interfere with the effectiveness of in vitro fertilization. Don't use vitex agnus-castus if you are undergoing this procedure.

Parkinson's disease. Vitex agnus-castus contains chemicals that affect the brain. These chemicals affect the brain similarly to some medications used for Parkinson's disease. Therefore, vitex agnus-castus might affect therapy for Parkinson's disease.

Schizophrenia or other psychotic disorders. Vitex agnus-castus seems to affect a chemical in the brain called dopamine. Some medications for mental disorders help to decrease dopamine. Therefore, taking vitex agnus-castus might affect therapy for certain mental disorders.

Interactions

Interactions?

Moderate Interaction

Be cautious with this combination

!
  • Birth control pills (Contraceptive drugs) interacts with VITEX AGNUS-CASTUS

    Vitex agnus-castus seems to change hormone levels in the body. Birth control pills contain hormones. Taking vitex agnus-castus along with birth control pills might decrease the effectiveness of birth control pills. If you take birth control pills along with vitex agnus-castus, use an additional form of birth control such as a condom.<br/><br/> Some birth control pills include ethinyl estradiol and levonorgestrel (Triphasil), ethinyl estradiol and norethindrone (Ortho-Novum 1/35, Ortho-Novum 7/7/7), and others.

  • Estrogens interacts with VITEX AGNUS-CASTUS

    Vitex agnus-castus seems to change hormone levels in the body. Taking vitex agnus-castus along with estrogen pills might decrease the effects of estrogen pills.<br/><br/> Some estrogen pills include conjugated equine estrogens (Premarin), ethinyl estradiol, estradiol, and others.

  • Medications for mental conditions (Antipsychotic drugs) interacts with VITEX AGNUS-CASTUS

    Vitex agnus-castus seems to affect a chemical in the brain called dopamine. Some medications for mental disorders help to decrease dopamine. Taking vitex agnus-castus along with medications for mental conditions might decrease the effectiveness of some medications for mental conditions.<br/><br/> Some medications for mental conditions include chlorpromazine (Thorazine), clozapine (Clozaril), fluphenazine (Prolixin), haloperidol (Haldol), olanzapine (Zyprexa), perphenazine (Trilafon), prochlorperazine (Compazine), quetiapine (Seroquel), risperidone (Risperdal), thioridazine (Mellaril), thiothixene (Navane), and others.

  • Medications used for Parkinson's disease (Dopamine agonists) interacts with VITEX AGNUS-CASTUS

    Vitex agnus-castus contains chemicals that affect the brain. These chemicals affect the brain similarly to some medications used for Parkinson's disease. Taking vitex agnus-castus with these medications might increase the effects and side effects of some medications used for Parkinson's disease.<br/><br/> Some medications used for Parkinson's disease include bromocriptine (Parlodel), levodopa (Dopar, component of Sinemet), pramipexole (Mirapex), ropinirole (Requip), and others.

  • Metoclopramide (Reglan) interacts with VITEX AGNUS-CASTUS

    Vitex agnus-castus seems to affect a certain brain chemical. This chemical is called dopamine. Metoclopramide (Reglan) also affects dopamine. Taking vitex agnus-castus along with metoclopramide might decrease the effectiveness of metoclopramide (Reglan).

Dosing

Dosing

The following doses have been studied in scientific research:

BY MOUTH:

  • For premenstrual dysphoric disorder (PMDD): 20-40 mg of vitex agnus-castus extract taken daily for 8 weeks has been used.
  • For premenstrual syndrome (PMS): A specific extract known as BNO 1095 (Agnucaston/Cyclodynon, Bionorica AG), which contains 4 mg of vitex agnus-castus extract has been taken daily for three menstrual cycles. Another specific extract known as Ze 440 (Prefemin, Max Zeller Sohne AG, Romanshorn, Switzerland) which contains 20 mg of vitex agnus-castus extract has been taken daily for three menstrual cycles. Another specific product (Femicur, Schaper & Brummer GmbH & Co. KG, Salzgitter, Germany) containing 6.4-12 mg of vitex agnus-castus extract has been taken daily in two divided doses for three menstrual cycles. Specific capsules (Agnolyt, Madaus AG, Cologne, Germany) containing 3.5-4.2 mg of vitex agnus-castus extract has been taken daily on days 16-35 over three menstrual cycles. Vitex agnus-castus extract, 40 drops added to one glass of fruit juice once daily before breakfast starting 6 days prior to menstrual bleeding and lasting until menstrual bleeding occurs, has been used for six cycles.

View References

REFERENCES:

  • Ben-Arye, E., Oren, A., and Ben-Arie, A. [Herbal medicine in womens' life cycle]. Harefuah 2006;145(10):738-42, 782. View abstract.
  • Bleier W. Therapie von Zyklus- und Blutungsstorungen und weiteren endokrin bedingten Erkrankungen der Frau mit pflanzlichen Wirkstoffen. Zbl Gynakol 1959;81:701-709.
  • Bubenzer RH. Therapy with Agnus castus extract (Strotan
  • Ciotta, L., Pagano, I., Stracquadanio, M., Di, Leo S., Ando, A., and Formuso, C. [Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: our experience with Vitex agnus castus]. Minerva Ginecol. 2011;63(3):237-245. View abstract.
  • Coeugniet E. Premenstrual syndrome and its treatment. Arztezeitchr Naturheilverf 1986;27:619-622.
  • Dante, G. and Facchinetti, F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom.Obstet.Gynaecol. 2011;32(1):42-51. View abstract.
  • Dennehy, C. E. The use of herbs and dietary supplements in gynecology: an evidence-based review. J Midwifery Womens Health 2006;51(6):402-409. View abstract.
  • Dittmar FW. Premenstrual syndrome: treatment with a phytopharmaceutical [in German]. TW Gynakologie 1992;5(1):60-68.
  • Doll, M. [The premenstrual syndrome: effectiveness of Vitex agnus castus]. Med.Monatsschr.Pharm. 2009;32(5):186-191. View abstract.
  • Dugoua, J. J., Seely, D., Perri, D., Koren, G., and Mills, E. Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation. Can.J Clin Pharmacol. 2008;15(1):e74-e79. View abstract.
  • Feldmann HU, Albrecht M, Lamertz M, and et al. The treatment of corpus Luteum insufficiency and premenstrual syndrome. Experience in a multicenter study under clinical practice conditions. [in German]. Gyne 1990;11(12):421-425.
  • Fersizoglou NE. Hormonale und thermographische veränderungen unter konservativer therapie der mastophathie. Vergleich von danazol, tamoxifen, lisurid, lynesterenol und einem phytopharmakon. Dissertation 1989;
  • Fikentscher, H. [Aetiology, diagnosis und therapy of mastopathy and mastodynia. Experiences of treatment with mastodynon (author's transl)]. Med Klin 8-26-1977;72(34):1327-1330. View abstract.
  • Fournier D and Grumbrecht C. Behandlung der mastopathie, mastodynie und des prämenstruellen syndroms. Verleich medikamentöser behandlung zu unbehandelten kontrollen. Therapiewoche 1987;37(5):430-434.
  • Freeman, E. W. Therapeutic management of premenstrual syndrome. Expert.Opin.Pharmacother. 2010;11(17):2879-2889. View abstract.
  • Fugh-Berman, A. and Kronenberg, F. Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reprod Toxicol. 2003;17(2):137-152. View abstract.
  • Göbel R. Results of the clinical evaluations of Danazol in benign breast disease compared with local treatment, gestagens, and bromocriptine. In: Baum M, George WD, and Hughes LE. Benign Breast Diseases. London: Roy Soc Med Int;1985.
  • Gregl A. Klinik und therapie der mastodynie. Med Welt 1985;36:242-246.
  • Halaska, M., Raus, K., Beles, P., Martan, A., and Paithner, K. G. [Treatment of cyclical mastodynia using an extract of Vitex agnus castus: results of a double-blind comparison with a placebo]. Ceska.Gynekol. 1998;63(5):388-392. View abstract.
  • Halder R. Über die anwendungsmoglichkeiten von vitex agnus-castus L. in der frauenheilkunde unter besonderer berücksichtigung der blutungsstörungen. Dissertation 1957;
  • He, Z., Chen, R., Zhou, Y., Geng, L., Zhang, Z., Chen, S., Yao, Y., Lu, J., and Lin, S. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China. Maturitas 5-20-2009;63(1):99-103. View abstract.
  • Jarry H, Leonhardt S, Wuttke W, and et al. [Agnus castus as a dopaminergic active constituent in Mastodynon N]. Zeitschrift fur Phytotherapie 1991;12:77-82.
  • Jarry, H., Spengler, B., Porzel, A., Schmidt, J., Wuttke, W., and Christoffel, V. Evidence for Estrogen Receptor beta-Selective Activity of Vitex agnus-castus and Isolated Flavones. Planta Med 2003;69(10):945-947. View abstract.
  • Kayser HW and Istanbulluoglu S. Vitex agnus castus. Hippokrates 1954;25:717-719.
  • Kubista, E., Muller, G., and Spona, J. [Treatment of mastopathies with cyclic mastodynia. Clinical results and hormonal profiles]. Rev Fr.Gynecol Obstet 1987;82(4):221-227. View abstract.
  • Laakmann, E., Grajecki, D., Doege, K., zu, Eulenburg C., and Buhling, K. J. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review. Gynecol.Endocrinol. 2012;28(9):703-709. View abstract.
  • Lauritzen, C., Reuter, H. D., Repges, R., Bohnert, K. J., and Schmidt, U. Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxine. Phytomedicine. 1997;4(3):183-189. View abstract.
  • Liebel H. Behandlung des prämenstruellen Syndromes. Agnus castus-haltige Kombinationsarzneimittel im Test. Therapiewoche Gynakol 1992;5:2-12.
  • Lucks, B. C., Sorensen, J., and Veal, L. Vitexagnus-castus essential oil and menopausal balance: a self-care survey. Complement Ther Nurs.Midwifery 2002;8(3):148-154. View abstract.
  • Ma, L., Lin, S., Chen, R., and Wang, X. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynecol.Endocrinol. 2010;26(8):612-616. View abstract.
  • Ma, L., Lin, S., Chen, R., Zhang, Y., Chen, F., and Wang, X. Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Aust.N.Z.J Obstet.Gynaecol. 2010;50(2):189-193. View abstract.
  • Mancho, P. and Edwards, Q. T. Chaste tree for premenstrual syndrome. An evolving therapy in the United States. Adv.Nurse Pract. 2005;13(5):43-4, 46. View abstract.
  • Mazaro-Costa, R., Andersen, M. L., Hachul, H., and Tufik, S. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women? J.Sex Med. 2010;7(11):3695-3714. View abstract.
  • Mergner R. Zyklusstörungen: therapie mit einem vitex-agnus-castus-haltigen kombinationsarzneimittel. Der Kassenarzt 1992;7:51-60.
  • Meyl C. Therapie des prämenstruellen syndroms. Vergleich einer kombinierten behandlung von mastodynon und vitamin E mit der vitamin E-monotherapie. Therapeutikon 1991;5(10):518-525.
  • Newton, K. M., Reed, S. D., Grothaus, L., Ehrlich, K., Guiltinan, J., Ludman, E., and Lacroix, A. Z. The Herbal Alternatives for Menopause (HALT) Study: background and study design. Maturitas 10-16-2005;52(2):134-146. View abstract.
  • Opitz, G. and Liebl, A. [Conservative treatment of mastopathy with Mastodynon]. Ther Ggw. 1980;119(7):804-809. View abstract.
  • Pearlstein, T. Psychotropic medications and other non-hormonal treatments for premenstrual disorders. Menopause.Int 2012;18(2):60-64. View abstract.
  • Pepeljnjak S, Antolic A, and Kustrak D. Antibacterial and antifungal activities of the Vitex agnus-castus L. extracts. Acta Pharmaceutica Zagreb 1996;46(3):201-206.
  • Peters-Welte C and Albrecht M. [Menstrual abnormalities and PMS. Vitex agnus-castus in a study of application]. Therapiewoche Gynakologie 1994;7(1):49-52.
  • Prilepskaya, V. N., Ledina, A. V., Tagiyeva, A. V., and Revazova, F. S. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas 2006;55(Suppl 1):S55-63.
  • Probst V and Roth OA. On a plant extract with a hormone-like effects. Deutsch Medizin Zeitschrift 1954;35:1271-1274.
  • Propping D, Katzorke T, and Belkien L. Diagnostik und therapie der gelbkorperschwache in der praxis. Therapiewoche 1988;38:2992-3001.
  • Propping D. Vitex agnus-castus: treatment of gynecological syndromes. [in German]. Therapeutikon 1991;5:581-585.
  • Roth OA. Zur therapie der gelbkörperinsuffizienz in der praxis. Med Klin 1956;51:1263-1265.
  • Schellenberg R, Schrader E, and Brattström A. Vitex agnus castus extrakt Ze440 bei pramenstruellem syndrom: ergebnisse einer RCT im vergleich mit plazebo bei 170 patientinnen. Abstracts Book - Symposium Phytopharmaka VII.Forschung und klinische anwendung, October 12-13 2001;
  • Schwalbe, E. [Treatment of mastodynia]. ZFA.(Stuttgart.) 8-10-1979;55(22):1239-1242. View abstract.
  • Singleton, G. Premenstrual disorders in adolescent females-- integrative management. Aust.Fam.Physician 2007;36(8):629-630. View abstract.
  • Sliutz, G., Speiser, P., Schultz, A. M., Spona, J., and Zeillinger, R. Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Horm.Metab Res 1993;25(5):253-255. View abstract.
  • Turner S and Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complementary Therapies in Medicine 1993;1(2):73-77.
  • van Die, M. D., Bone, K. M., Burger, H. G., and Teede, H. J. Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial. BMC.Med.Res Methodol. 2009;9:41. View abstract.
  • van Die, M. D., Bone, K. M., Burger, H. G., Reece, J. E., and Teede, H. J. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis. J.Altern.Complement Med. 2009;15(9):1045-1048. View abstract.
  • van Die, M. D., Burger, H. G., Bone, K. M., Cohen, M. M., and Teede, H. J. Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial. Menopause. 2009;16(1):156-163. View abstract.
  • van Die, M. D., Burger, H. G., Teede, H. J., and Bone, K. M. Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern.Complement Med. 2009;15(8):853-862. View abstract.
  • van Die, M. D., Teede, H. J., Bone, K. M., Reece, J. E., and Burger, H. G. Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause. Menopause. 2009;16(4):792-796. View abstract.
  • Westphal, L. M., Polan, M. L., and Trant, A. S. Double-blind, placebo-controlled study of Fertilityblend: a nutritional supplement for improving fertility in women. Clin Exp.Obstet.Gynecol. 2006;33(4):205-208. View abstract.
  • Westphal, L. M., Polan, M. L., Trant, A. S., and Mooney, S. B. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med. 2004;49(4):289-293. View abstract.
  • Whelan, A. M., Jurgens, T. M., and Naylor, H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can.J.Clin.Pharmacol. 2009;16(3):e407-e429. View abstract.
  • Winterhoff H, Gorkow C, and Behr B. Die Hemmung der Laktation bei Ratten als indirekter Beweis fur die Senkung von Prolaktin durch Agnus castus. Zeitschrift fur Phytotherapie 1991;12:175-179.
  • World Health Organization. Monographs on Selected Medicinal Plants. 2004;4
  • Wuttke W, Splitt G, Gorkow C, and et al. Behandlung zyklusabhangiger brustschmerzen mit einem Agnus castus-haltigen arzneimittel [Treatment of cyclical mastalgia: Results of a randomized, placebo-controlled, double-blind study]. Geburtsh.u.Frauenheilk 1997;57:569-574.
  • Zamani, M., Neghab, N., and Torabian, S. Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome. Acta Med.Iran 2012;50(2):101-106. View abstract.
  • Artz MB. Vitex agnus-castus. In Herbal Products: Toxicology and Clinical Pharmacology, Second Edition. Ed. Tracy TS, Kingston RL. Humana Press Inc., Totowa, NJ: 2007.
  • Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol 2003;18:191-5.. View abstract.
  • Berger D, Schaffner W, Schrader E, et al. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with premenstrual syndrome (PMS). Arch Gynecol Obstet 2000;264:150-3. View abstract.
  • Bergmann, J., Luft, B., Boehmann, S., Runnebaum, B., and Gerhard, I. [The efficacy of the complex medication Phyto-Hypophyson L in female, hormone-related sterility. A randomized, placebo-controlled clinical double-blind study]. Forsch Komplementarmed Klass Naturheilkd 2000;7(4):190-199. View abstract.
  • Brown D. Vitex agnus castus clinical monograph. Qtrly Rev Natural Med 1994;2:111-21.
  • Cahill DJ, Fox R, Wardle PG, et al. Multiple follicular development associated with herbal medicine. Hum Reprod 1994;9:1469-70. View abstract.
  • Daniele C, Thompson Coon J, Pittler MH, Ernst E. Vitex agnus castus: a systematic review of adverse events. Drug Saf 2005;28:319-32.. View abstract.
  • Dinç T, Coskun F. Comparison of fructus agni casti and flurbiprofen in the treatment of cyclic mastalgia in premenopausal women. Ulus Cerrahi Derg. 2014 Mar 1;30(1):34-8 View abstract.
  • Dixon-Shanies D, Shaikh N. Growth inhibition of human breast cancer cells by herbs and phytoestrogens. Oncol Rep 1999;6:1383-7.. View abstract.
  • Du Mee C. Vitex agnus castus. Aust J Med Herb 1993;5:63-5.
  • Eagon PK, Elm MS, Hunter DS, et al. Medicinal herbs: modulation of estrogen action. Era of Hope Mtg, Dept Defense; Breast Cancer Res Prog, Atlanta, GA 2000;Jun 8-11.
  • Eftekhari MH, Rostami ZH, Emami MJ, Tabatabaee HR. Effects of "vitex agnus castus" extract and magnesium supplementation, alone and in combination, on osteogenic and angiogenic factors and fracture healing in women with long bone fracture. J Res Med Sci. 2014 Jan;19(1):1-7. View abstract.
  • Gerhard II, Patek A, Monga B, et al. Mastodynon for female infertility. (abstract) Forsch Komplementarmed 1998;5:272-8. View abstract.
  • Halaska M, Beles P, Gorkow C, Sieder C. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. Breast 1999;8:175-81. View abstract.
  • Hossain MM, Paul N, Sohrab MH, et al. Antibacterial activity of Vitex trifolia. Fitoterapia 2001;72:695-7. View abstract.
  • Jarry H, Leonhardt S., Gorkow C, Wuttke W. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus Castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol 1994;102:448-54. View abstract.
  • Krapfl E. Prospektiv randomisierte klinische thrapiestudie zum wirksamkeitsvergleich von Orgametril&reg;, einem 19 nor-testosteron-derivat, versus Mastodynon&reg;, agnus castus-haltigen alkoholischen pflanzenextrakt, bei schmerzhafter mastopathie. Dissertation 1988;
  • Lauritzen CH, Reuter HD, Repges R, et al. Treatment of premenstrual tension syndrome with Vitex agnus castus: Controlled-double blind versus pyridoxine. Phytomedicine 1997;4:183-9.
  • Liu J, Burdette JE, Sun Y, et al. Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnus-castus L. (chaste-berry). Phytomedicine 2004;11:18-23. View abstract.
  • Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472-9.. View abstract.
  • Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med 2000;9:315-20. View abstract.
  • Mehlhorn H, Schmahl G, Schmidt J. Extract of the seeds of the plant Vitex agnus castus proven to be highly efficacious as a repellent against ticks, fleas, mosquitoes and biting flies. Parasitol Res 2005;95:363-5. View abstract.
  • Meier B, Berger D, Hoberg E, et al. Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine 2000;7:373-81. View abstract.
  • Merz P, Gorkow C, Schroder A, et al. The effects of a special Agnus castus extract (BP1095el) on prolactin secretion in healthy male subjects. Exp Clin Endocrinol Diabetes 1996;104:447-53. View abstract.
  • Milewicz A, Gejdel E, Sworen H, et al. [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study]. Arzneimittelforschung 1993;43:752-6.. View abstract.
  • Momoeda M, Sasaki H, Tagashira E, Ogishima M, Takano Y, Ochiai K. Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study. Adv Ther. 2014 Mar;31(3):362-73. View abstract.
  • Ohyama K, Akaike T, Hirobe C, Yamakawa T. Cytotoxicity and apoptotic inducibility of Vitex agnus-castus fruit extract in cultured human normal and cancer cells and effect on growth. Biol Pharm Bull 2003;26:10-18. View abstract.
  • Okuyama E, Fujimori S, Yamazaki M, Deyama T. Pharmacologically active components of viticis fructus (Vitex rotundifolia). II. The components having analgesic effects. Chem Pharm Bull (Tokyo) 1998;46:655-62. View abstract.
  • Ono M, Yanaka T, Yamamoto M, et al. New diterpenes and norditerpenes from the fruits of Vitex rotundifolia. J Nat Prod 2002;65:537-41. View abstract.
  • Prilepskaya VN, Ledina AV, Tagiyeva AV, Revazova FS. Vitex agnus castus: Successful treatment of moderate to severe premenstrual syndrome. Maturitas 2006;55 Suppl 1:S55-63.
  • Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117-22. View abstract.
  • Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo-controlled study. BMJ 2001;322:134-7. View abstract.
  • Shin TY, Kim SH, Lim JP, et al. Effect of Vitex rotundifolia on immediate-type allergic reaction. J Ethnopharmacol 2000;72:443-50. View abstract.
  • Turner S, Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: a case study. Complement Ther Med 1993;1:73-77.
  • Upton R, ed. Chaste Tree Fruit. American Herbal Pharmacopoeia and Therapeutic Compendium. Santa Cruz, CA; American Herbal Pharmacopoeia 2001:1-37.
  • Van Die MD, Burger HC, Teede HG, Bone KM. Vitex agnus castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med 2013:79:562-575. View abstract.
  • Wuttke W, Jarry H, Christoffel V, et al. Chaste tree (Vitex agnus-castus)--pharmacology and clinical indications. Phytomedicine 2003;10:348-57. View abstract.
  • Wuttke W. Dopaminergic action of extracts of Agnus Castus. Forschende Komplementarmedizen 1996;3:329-30.
  • Yavarikia P, Shahnazi M, Hadavand Mirzaie S, Javadzadeh Y, Lutfi R. Comparing the effect of mefenamic Acid and vitex agnus on intrauterine device induced bleeding. J Caring Sci. 2013 Aug 31;2(3):245-54. View abstract.

More Resources for VITEX AGNUS-CASTUS

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version. © Therapeutic Research Faculty 2009.